We discover, develop and deliver affordable, innovative medicines that help our patients prevail over serious diseases. Their well-being and convenience are top priority for us. Biocon’s innovative science and products have disrupted the healthcare process in developed countries that saw life-saving medicines accessible to only a few. We are committed to respecting the patient community’s independence and to working in a simple, transparent way.

Research & Development forms the bedrock of Biocon’s mission to deliver affordable therapeutics that address unmet patient needs. Our primary focus is on diabetes, cancer and autoimmune diseases. However, we constantly adapt and track the latest insights, to let science show us the way forward. Biocon’s core R&D philosophy is focussed on developing select high potential molecules that are at the forefront of technological innovation. We use deep science and cutting-edge R&D to create disruptive solutions and offer affordable alternatives to some of the world’s most expensive medicines.

Nearly 2 billion people, a third of the world’s population, lack access to essential medicines; and where healthcare does exist, it is unaffordable. It is time to shift the debate from high-priced, advanced therapeutics to affordable innovation, from market strategies to medical solutions, from mitigating cost to unlocking value. In doing so, we aim to deliver our medicines to as many people as possible and create better patient outcomes. By leveraging India’s scientific advantage, we are moderating costs and widening patient access through high-quality specialty products for chronic ailments such as diabetes, cancer and autoimmune diseases.

We are committed to maintaining the highest quality standards. Our regulatory and quality systems are robust, best-in-class and of global standards. They have earned us the trust of patients, doctors, caregivers, partners and healthcare ecosystems around the world.

We believe that real, sustainable growth is possible when industry interests are balanced with societal interests. We aim to make a difference by changing the healthcare dynamics and making high-quality, affordable medicine accessible to more than a billion people. Our strong sense of ethics drives us in creating long-term value for all our stakeholders.

Our people are our biggest asset. They fuel innovation in our pipeline and hold true to our commitment of exploring the unexplored in medicine. Our deep-rooted entrepreneurial culture attracts the brightest talent. We strive to maintain an environment that values our diverse workforce, constantly motivating them to realise their full potential.